Cwm, LLC Sarepta Therapeutics, Inc. Transaction History

Cwm, LLC

$33.3 Billion
Q3 2025

A detailed history of Cwm, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Cwm, LLC holds 72,705 shares of SRPT stock, worth $1.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

72,705

Previous 1,759 4033.31%

Holding current value

$1.37 Million

Previous $30,000 4570.0%

% of portfolio

0.0%

Previous 0.0%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 15, 2025	BUY	$11.93 - $21.97 $846,385 - $1.56 Million	70,946 Added 4033.31%	72,705 $1.4 Million
Q2 2025 Jul 25, 2025	BUY	$17.1 - $63.66 $14,483 - $53,920	847 Added 92.87%	1,759 $30,000
Q1 2025 May 01, 2025	BUY	$63.82 - $127.89 $4,850 - $9,719	76 Added 9.09%	912 $58,000
Q4 2024 Feb 04, 2025	SELL	$104.54 - $137.94 $5,436 - $7,172	-52 Reduced 5.86%	836 $102,000
Q3 2024 Oct 08, 2024	BUY	$124.33 - $156.75 $2,113 - $2,664	17 Added 1.95%	888 $111,000

Q2 2024 Jul 09, 2024	BUY	$113.33 - $163.85 $23,005 - $33,261	203 Added 30.39%	871 $138,000
Q1 2024 Apr 05, 2024	BUY	$93.7 - $141.53 $8,526 - $12,879	91 Added 15.77%	668 $86,000
Q4 2023 Feb 01, 2024	BUY	$67.31 - $124.76 $24,904 - $46,161	370 Added 178.74%	577 $56,000
Q3 2023 Oct 11, 2023	SELL	$102.5 - $123.59 $7,585 - $9,145	-74 Reduced 26.33%	207 $25,000
Q2 2023 Aug 03, 2023	BUY	$106.4 - $157.19 $6,703 - $9,902	63 Added 28.9%	281 $32,000
Q1 2023 Apr 28, 2023	BUY	$117.53 - $155.99 $8,697 - $11,543	74 Added 51.39%	218 $30,000
Q4 2022 Feb 01, 2023	BUY	$100.86 - $132.13 $5,547 - $7,267	55 Added 61.8%	144 $19,000
Q3 2022 Oct 27, 2022	BUY	$75.71 - $119.24 $3,861 - $6,081	51 Added 134.21%	89 $10,000
Q2 2022 Jul 28, 2022	SELL	$62.69 - $88.44 $5,015 - $7,075	-80 Reduced 67.8%	38 $3,000
Q1 2022 Apr 21, 2022	BUY	$63.15 - $90.42 $2,336 - $3,345	37 Added 45.68%	118 $9,000
Q4 2021 Jan 31, 2022	BUY	$77.28 - $99.42 $5,023 - $6,462	65 Added 406.25%	81 $7,000
Q1 2021 Sep 15, 2021	SELL	$72.25 - $168.95 $505 - $1,182	-7 Reduced 30.43%	16 $1,000
Q1 2021 Apr 27, 2021	BUY	$72.25 - $168.95 $505 - $1,182	7 Added 43.75%	23 $2,000
Q4 2020 Sep 15, 2021	SELL	$125.56 - $178.74 $3.62 Million - $5.15 Million	-28,840 Reduced 99.94%	16 $1,000
Q4 2020 Jan 27, 2021	BUY	$125.56 - $178.74 $3.62 Million - $5.15 Million	28,840 Added 180250.0%	28,856 $4.92 Million
Q3 2020 Sep 15, 2021	BUY	$127.12 - $172.34 $1,398 - $1,895	11 Added 220.0%	16 $1,000
Q3 2020 Oct 19, 2020	SELL	$127.12 - $172.34 $1,398 - $1,895	-11 Reduced 68.75%	5 $1,000
Q2 2020 Sep 15, 2021	BUY	$93.0 - $171.7 $1,488 - $2,747	16 New	16 $1,000
Q2 2020 Jul 22, 2020	SELL	$93.0 - $171.7 $1,488 - $2,747	-16 Closed	0 $0
Q1 2020 Sep 15, 2021	SELL	$82.38 - $131.64 $6,919 - $11,057	-84 Reduced 84.0%	16 $1,000
Q1 2020 Apr 28, 2020	BUY	$82.38 - $131.64 $6,919 - $11,057	84 Added 525.0%	100 $10,000
Q4 2019 Sep 14, 2021	SELL	$76.53 - $135.58 $3,596 - $6,372	-47 Reduced 74.6%	16 $1,000
Q4 2019 Jan 27, 2020	BUY	$76.53 - $135.58 $3,596 - $6,372	47 Added 293.75%	63 $8,000
Q3 2019 Sep 14, 2021	SELL	$72.81 - $156.91 $509 - $1,098	-7 Reduced 30.43%	16 $1,000
Q3 2019 Oct 22, 2019	BUY	$72.81 - $156.91 $509 - $1,098	7 Added 43.75%	23 $2,000
Q2 2019 Sep 14, 2021	SELL	$112.21 - $151.95 $785 - $1,063	-7 Reduced 30.43%	16 $1,000
Q2 2019 Jul 31, 2019	BUY	$112.21 - $151.95 $785 - $1,063	7 Added 43.75%	23 $3,000
Q1 2019 Sep 02, 2021	SELL	$106.67 - $151.68 $746 - $1,061	-7 Reduced 30.43%	16 $0
Q4 2018 Jan 25, 2019	BUY	$97.32 - $148.76 $2,238 - $3,421	23 New	23 $3,000

Others Institutions Holding SRPT

# of Institutions

406

Shares Held

83.7M

Call Options Held

5.27M

Put Options Held

5.94M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $1.65B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account